VSEC Q1 2026 Earnings EPS Surges 2776 Above Estimates Amid Operational Strength CSX Q1 2026 Earnings EPS Surprise Drives Profit Beat but Stock Declines GRO Q1 2026 Earnings WiderThanExpected Loss as Development Continues ADIL Q1 2026 Earnings Narrowed Loss Beats Estimates but Market Remains Cautious TransCode Therapeutics Q4 2024 Earnings Deep Losses Reflect PreRevenue Stage Genprex GNPX Q1 2026 Earnings Continued RD Investment as Gene Therapy Pipeline Progresses